More than 1,900 Springer Protocols eBooks at just $9.99 each! Get yours today>>

Advances in Experimental Medicine and Biology

Polymer Drugs in the Clinical Stage

Advantages and Prospects

Editors: Maeda, H., Kabanov, A., Kataoka, K., Okano, T. (Eds.)

Buy this book

eBook $189.00
price for USA (gross)
  • ISBN 978-0-306-47932-8
  • Digitally watermarked, DRM-free
  • Included format: PDF
  • ebooks can be used on all reading devices
  • Immediate eBook download after purchase
Hardcover $259.00
price for USA
valid through October 16, 2017
  • ISBN 978-0-306-47471-2
  • Free shipping for individuals worldwide
  • Usually dispatched within 3 to 5 business days.
Softcover $249.00
price for USA
  • ISBN 978-1-4757-7840-3
  • Free shipping for individuals worldwide
  • Usually dispatched within 3 to 5 business days.
About this book

Proceedings of the International Symposium on Polymer Therapeutics - Recent Progress in Clinics and Future Prospects, held July 13-14, 2001, in Nara, Japan.

The technology of polymer science has developed considerably during the past half-century, and this volume describes some of the aspects of this technology that will have a great impact in the future. Among these advances, for example, are gene delivery to specific disease sites and carrier polymers that respond to a stimulus or particular environment. Cancer targeted drug delivery is another focused area of this volume because of the important nature of EPR-effect of polymer drugs in tumor. Included are discussions of as many examples as possible of polymer drugs that have achieved, or are close to clinical use. The concept of "Polymer drugs" here is limited to primarily injectable and water-soluble agents, although also covered are some drugs in micellar form or liposomes.

This book is intended for students and researchers in the field of pharmacology who have particular interests in drug delivery, targeting, and formulation, as well as for clinicians such as oncologists who are interested in the field. People who work at regulatory agencies should also be aware such that drugs with great potential are being developed and will be beneficial to many patients, as well as to health insurance agencies because of improved cost effectiveness.

Table of contents (13 chapters)

  • Challenges in Polymer Therapeutics

    Kabanov, Alexander V. (et al.)

    Pages 1-27

  • Factors and Mechanism of “EPR” Effect and the Enhanced Antitumor Effects of Macromolecular Drugs Including SMANCS

    Fang, Jun (et al.)

    Pages 29-49

  • PEG-Adenosine Deaminase and PEG-Asparaginase

    Davis, Frank F.

    Pages 51-58

  • Peginterferon alfa-2a (40KD): A Potent Long-Acting Form of Interferon alfa-2a for the Treatment of Hepatitis C

    Modi, Marlene W. (et al.)

    Pages 59-67

  • PEG-Methioninase

    Hoffman, Robert M.

    Pages 69-79

Buy this book

eBook $189.00
price for USA (gross)
  • ISBN 978-0-306-47932-8
  • Digitally watermarked, DRM-free
  • Included format: PDF
  • ebooks can be used on all reading devices
  • Immediate eBook download after purchase
Hardcover $259.00
price for USA
valid through October 16, 2017
  • ISBN 978-0-306-47471-2
  • Free shipping for individuals worldwide
  • Usually dispatched within 3 to 5 business days.
Softcover $249.00
price for USA
  • ISBN 978-1-4757-7840-3
  • Free shipping for individuals worldwide
  • Usually dispatched within 3 to 5 business days.
Loading...

Recommended for you

Loading...

Bibliographic Information

Bibliographic Information
Book Title
Polymer Drugs in the Clinical Stage
Book Subtitle
Advantages and Prospects
Editors
  • Hiroshi Maeda
  • Alexander Kabanov
  • Kazunori Kataoka
  • Teruo Okano
Series Title
Advances in Experimental Medicine and Biology
Series Volume
519
Copyright
2003
Publisher
Springer US
Copyright Holder
Springer Science+Business Media New York
eBook ISBN
978-0-306-47932-8
DOI
10.1007/b105364
Hardcover ISBN
978-0-306-47471-2
Softcover ISBN
978-1-4757-7840-3
Series ISSN
0065-2598
Edition Number
1
Number of Pages
VIII, 226
Topics